Table 4: Sinus rhythm and

antiarrhythmic drug treatment post-PVI.

Variables

3 months

± ١ month

n (%)

6 months

± ١ month

n (%)

12 months

± ١ month

n (%)

Subjects in sinus rhythm

74 (100.0)

74 (100.0)

71 (95.9)

Subjects with

antiarrhythmic treatment

74 (100.0)

30 (40.5)

15 (20.3)

Antiarrhythmic treatment

Amiodarone

63 (85.1)

23 (76.7)

12 (80.0)

Propafenone

8 (10.8)

5 (16.7)

2 (13.3)

Dronedarone

1 (1.4)

1 (3.3)

0 (0)

Metoprolol

2 (2.7)

1 (3.3)

1 (6.7)